Carbamate → tetrahydro-2H-pyran-4-yl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate

HRID 2093446ノート

反応式

HRID 2093446 の反応式
[F:1][C:2]1[C:21]([NH:22][C:23]([NH:25]C2C=CN=C(C)C=2)=[O:24])=[CH:20][CH:19]=[CH:18][C:3]=1[CH2:4][N:5]1[CH2:10][CH2:9][N:8]([C:11]([O:13][C:14]([CH3:17])([CH3:16])C)=[O:12])[CH2:7][CH2:6]1.Cl.CCN(CC)CC.[CH:41]1[C:46]([N+:47]([O-])=O)=[CH:45][CH:44]=[C:43]([Cl-]C([O-])=O)[CH:42]=1.OC1C[CH2:59][O:58][CH2:57]C1.[H-].[Na+].C(=O)([O-])N>CO.C(Cl)Cl>[F:1][C:2]1[C:21]([NH:22][C:23]([NH:25][C:43]2[CH:42]=[N:47][C:46]([CH3:41])=[CH:45][CH:44]=2)=[O:24])=[CH:20][CH:19]=[CH:18][C:3]=1[CH2:4][N:5]1[CH2:10][CH2:9][N:8]([C:11]([O:13][CH:14]2[CH2:16][CH2:59][O:58][CH2:57][CH2:17]2)=[O:12])[CH2:7][CH2:6]1

参加物

9

反応物 6

HCID 276CarbamateHCID 313Hydrochloric AcidHCID 8471TriethylamineHCID 24758Sodium hydrideHCID 74956Tetrahydro-4H-pyran-4-olHCID 58919226Tert-butyl 4-(2-fluoro-3-(3-(2-methylpyridin-4-yl)ureido)benzyl)piperazine-1-carboxylate

生成物 1

HCID 23641368tetrahydro-2H-pyran-4-yl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate収率 39%

試薬・触媒・溶媒 2

HCID 887Methanol溶媒HCID 6344Dichloromethane溶媒

実験手順

To a solution of tert-butyl 4-(2-fluoro-3-(3-(2-methylpyridin-4-yl)ureido)benzyl)piperazine-1-carboxylate (1.0 g, 2.26 mmol, 1.0 equiv) in MeOH (10 mL) was added HCl (4N in dioxane, 10 mL, 40 mmol, 17.7 equiv). The mixture was stirred for 30 min, and the solvent was then removed in vacuo. The residue was suspended in dry DCM (20 mL) and Et3N (1.64 mL, 11.79 mmol, 5.2 equiv). To the resulting mixture was added 4-nitrophenylchloroformate (500 mg, 2.49 mmol, 1.1 equiv). The resulting solution was stirred for 30 min, diluted with DCM, washed with aq NH4Cl and brine and concentrated in vacuo. The resulting residue was divided into three equal portions for subsequent derivitization. To a solution of 4-hydroxytetrahydropyran (190 μL, 2 mmol, 2.65 equiv) was added NaH (120 mg of 60% dispersion in mineral oil, 3.0 mmol, 4 equiv) after stirring for 10 minutes, the activated carbamate was added to the reaction mixture, and the reaction was stirred at room temperature overnight. The excess NaH was quenched by the careful addition of water, and the reaction mixture was diluted with ethyl acetate. The organic layer was washed repeatedly with water and once with brine, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative reverse phase HPLC provided tetrahydro-2H-pyran-4-yl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate (140 mg, 39%). LCMS m/z (APCI)=472.2 (M+H).

後処理

  1. customthe solvent was then removed in vacuo
  2. stirringThe resulting solution was stirred for 30 min
  3. washwashed with aq NH4Cl and brine
  4. concentrationconcentrated in vacuo
  5. stirringafter stirring for 10 minutes
  6. stirringthe reaction was stirred at room temperature overnight
  7. customThe excess NaH was quenched by the careful addition of water
  8. additionthe reaction mixture was diluted with ethyl acetate
  9. washThe organic layer was washed repeatedly with water and once with brine
  10. dry with materialdried over sodium sulfate
  11. concentrationconcentrated in vacuo
  12. customPurification by preparative reverse phase HPLC

出典と根拠

ORDレコード
ord-a25365033d7f4f8eace7e6059e3cc721
出典データセット
uspto-grants-2013_05
特許番号
US08445495B2

反応ノート

読み込み中…